Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$22.4M
3 rounds on record
Latest round
$13.3M
Venture round · Jul 2019 · 7 yr ago
Team
51-200
employees, estimated range
Revenue
$1M
2018 · SEC Form D 0001447734-19-000003
Backers
1
Irrus Investments
The money's age
Long since its last round
86 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3, 2024
Board appointment Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors · globenewswire
Jan 16, 2024
Certified Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indi… · globenewswire
Dec 19, 2022
Board appointment Aruna Bio Announces Appointment of Mike Ryan to its Board of Directors · globenewswire.com
Apr 27, 2022
New executive ARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER · PRNewswire
Sep 23, 2021
Board appointment Aruna Bio Appoints John Richard to Board of Directors · PRNewswire
Jul 19, 2019
Raised a round Venture round $13.3M · SEC Form D
Jul 7, 2018
Raised a round Venture round $5.4M · SEC Form D
Aug 10, 2016
Raised a round Venture round $3.7M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2019 | $13.3M | — | SEC Form D |
| Venture round | Jul 2018 | $5.4M | — | SEC Form D |
| Venture round | Aug 2016 | $3.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | ArunA Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Harold IngallsDirectorSEC Form D
Mark SirgoExecutive Officer, DirectorSEC Form D
Steven SticeExecutive Officer, DirectorSEC Form D
Tracey SticeExecutive OfficerSEC Form D
Al MedwarExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Irrus Investments Similar startupsby what they do, their industry and backers
Verge Labs has spent a decade building one of the most comprehensive proprietary human tissue datasets in neurological disease.
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
Advancing sustainable energy possibilities with Elysium Energy.
Unlocking resiliencefor the chemical industry.
Transform biology with 310 AI’s generative models - unlocking new possibilities in medicine, industry, environmental engineering, and…
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Overview
Unlocking new possibilities for millions with neurological disease.
News
Aruna's Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
BOSTON and ATHENS, Ga., March 31, 2025 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of...
Read more
Report
Aruna Bio Announces Issuance of U.S. Patent for Method of Use for Neural Exosomes Used to Reduce Inflammation in the Brain
BOSTON and ATHENS, Ga., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of...
Read more
Report
Aruna Bio Announces Issuance of U.S. Patent for Composition of Matter for Neural Exosomes Used to Deliver Therapeutics to the Brain
On track to initiate Phase 1b/2a clinical trial of AB126 in acute ischemic stroke in 2H 2024...
Read more
Report
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
BOSTON and ATHENS, Ga., June 03, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of...
Read more
Report
Aruna Bio to Participate in Upcoming Investor Conferences
BOSTON and ATHENS, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of...
Read more
Report
Pro access
Upgrade to see all 35 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Harold Ingalls
Director
Mark Sirgo
Executive Officer, Director
Steven Stice
Executive Officer, Director
Tracey Stice
Executive Officer
Al Medwar
Executive Officer
Darren DeVore
Director
C. William Griffin
Director
Mason Irving
Director
John Mangan
Director
Russell Lindner
Director
Barry Storey
Director
John Mangan Jr.
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Athens
United States
HQ
50-200 est. staff
Financials
Est. Annual Revenue
$500k
2018
Total raised
$22.4M
Latest round
Venture - Series Unknown
Funding rounds
3
Revenue
0% YoY
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2015 | $500k | $1 | $1M |
| 2016 | $500k | $1 | $1M |
| 2017 | $500k | $1 | $1M |
| 2018 | $500k | $1 | $1M |